C
CRISPR Therapeutics
CRSP · NASDAQ · Healthcare
$53.52
+$1.95 (+3.64%) today
Loading live data...
Market Cap
$5.17B
24h Volume
$68.6M
P/E Ratio
-8.5
52w High
$76.78
52w Low
$44.34
Est. AI Revenue
8%
Loading chart data...
7-Day Sparkline (Static)
About CRISPR Therapeutics
Gene-editing biotechnology company applying AI/ML to optimize CRISPR guide RNA design and therapeutic target identification.
CEO: Samarth Kulkarni
Founded: 2013
HQ: Zug, Switzerland
Employees: 1,200
Performance
24 Hours+3.64%
7 Days+11.52%
30 Days-5.01%
1 Year-2.69%